Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Fosun Pharma Lands $107 Million to Build African Production and Distribution Facility

publication date: Jun 8, 2023

Shanghai Fosun Pharma will partner with the International Finance Corp, a World Bank affiliate, to build a pharmaceutical production facility and distribution hub for Africa in the Ivory Coast. The IFC will issue two loans worth a total of $107 million to help underwrite the cost. The project, which was launched in November 2022, will consist of three phases, ultimately building a manufacturing plant with the capacity to make 5 billion medicine tablets annually. Fosun said the new facilities will support better healthcare delivery in West Africa, especially for malaria and antibacterial medicines. More details....

Stock Symbols: (SHA: 600196; HK: 02196)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital